The Label Is a Promise. Absorption Is the Product.
A supplement you don't absorb is a supplement you didn't take. The receipt says otherwise, but your enterocytes keep better books than your credit card.
In practice, I used to write elegant protocols. Magnesium glycinate at night, methylated B complex in the morning, D3 with the largest meal. Then the patient would go to the drugstore, find a bottle that said "Magnesium 500 mg" for six dollars, and buy that instead. I can't blame them. The label made the same promise mine did, in the same font. The difference was invisible unless you knew what "as magnesium oxide" meant in the fine print, and almost nobody does.
That gap between what I prescribed and what got swallowed is a large part of why I ended up formulating a catalog instead of just recommending one.
Minerals: the form is the dose
Elemental magnesium is not the number that matters. What matters is how much of it crosses the intestinal wall, and that depends almost entirely on what the magnesium is attached to.
Magnesium oxide is cheap, dense, and poorly absorbed. The most cited human study on it found fractional absorption around 4 percent. The rest stays in the gut lumen, pulls water in osmotically, and exits the way unabsorbed osmotic agents do. This is why magnesium oxide is a fine laxative and a mediocre magnesium supplement.
We stock magnesium glycinate. The magnesium is chelated to two glycine molecules, which changes the absorption route. Instead of competing at saturable mineral channels, a portion of the chelate is taken up through amino acid transport pathways. That is shown for glycinate chelates generally; the exact fraction varies by study and by gut. What I can say with confidence is that glycinate delivers meaningfully more absorbed magnesium per milligram swallowed, and it does it without sending you to the bathroom. The glycine itself is a bonus. It is a calming inhibitory neurotransmitter precursor, which is why it earns the evening slot when your pack architecture has one.
Same logic for calcium. We use calcium citrate, not carbonate. Carbonate needs stomach acid to dissociate, which makes it a poor choice for anyone over fifty, anyone on a proton pump inhibitor, and anyone taking it between meals. Citrate is already an organic acid salt. It absorbs with or without gastric acid. Carbonate packs more elemental calcium per capsule, and that is exactly why it dominates the shelf: it is a manufacturing decision dressed up as a nutrition decision.
Zinc follows the pattern. Chelated forms outperform the oxide. Zinc oxide is nearly insoluble at intestinal pH, which is a polite way of saying you are swallowing a mineral pigment.
The chelation principle is worth stating once, generally, because it applies across the mineral aisle. A bare mineral ion in the gut is a charged particle in a hostile environment. It binds phytates from your breakfast oatmeal, precipitates with phosphates, and fights every other divalent cation for a limited number of transport channels. Calcium, magnesium, zinc, iron, copper: same channels, same traffic jam. Wrap that ion in amino acids and you change its identity at the border. The chelate is more stable through pH swings, less reactive with dietary inhibitors, and eligible for peptide and amino acid uptake routes the bare ion never sees. You are not upgrading the mineral. The mineral is the same element it was in the mine. You are upgrading its paperwork. This is also why chelates are gentler: less unabsorbed mineral sitting in the lumen means less osmotic drag, less oxidative irritation, less of the GI complaint that makes people quit iron and magnesium in week two. The chelate costs more per kilogram and takes up more capsule space per milligram of elemental mineral. Those are the two reasons the industry mostly doesn't use them.
B vitamins: some people can't run the conversion
Cyanocobalamin is B12 with a cyanide group where a methyl group should be. The cyanide is not dangerous at these doses. It is just useless. Your body has to strip it off, then attach a methyl group, before the molecule can do its job in methionine synthase. Most people run this conversion fine. Some run it slowly.
We stock methylcobalamin, the form your enzymes actually use. Same story with folate. Folic acid is synthetic and has to pass through dihydrofolate reductase, an enzyme with famously limited capacity in the human liver, before it becomes anything biologically active. Roughly 40 percent of people carry at least one MTHFR variant that further slows the downstream conversion to 5-MTHF. So we skip the bottleneck and stock methylfolate, the end product, directly. For most people the difference is modest. For the person with two slow alleles and a decade of unexplained homocysteine elevation, it is the whole game. I have met that person in clinic more than once. The bloodwork changes when the form changes and nothing else does.
Is methylfolate proven superior to folic acid for the general population? No. The population data does not show that. What is established is that methylfolate reaches the same or higher blood folate levels without producing unmetabolized folic acid in circulation, a compound we still don't fully understand the consequences of. When two forms cost me a few cents apart and one carries an open biochemical question, I formulate around the question.
The pattern extends across the B complex, because the Bs are not nutrients so much as enzyme cofactors wearing nutrient costumes. What your cells use is never the vitamin on the label. It is the activated coenzyme: B6 works as pyridoxal-5-phosphate, riboflavin works as FAD, B12 works as methylcobalamin or adenosylcobalamin. Every one of those activations is an enzymatic step, and every enzymatic step is a place where genetics, age, medication, or alcohol can slow the line. So where the activated form is stable enough to put in a capsule, we stock the activated form. P5P instead of pyridoxine hydrochloride is the other example I care about, because pyridoxine has a strange property: at high doses the unconverted precursor appears to compete with its own active form, and pyridoxine, not P5P, is the form implicated in the sensory neuropathy reports that gave B6 its scary reputation. Skipping the conversion sidesteps the traffic jam and, I suspect, some of the toxicity. That last clause is my read of a thin literature. It is a formulation preference, not a settled fact.
There is one more reason the methylated Bs travel together in our formulas rather than as soloists. Methylation is a cycle, not a reaction. Methylfolate donates its methyl group to B12, B12 hands it to homocysteine to regenerate methionine, and B2 and B6 service the enzymes that keep the wheel turning. Supplementing one methylated B while another sits deficient is like restocking one station on an assembly line. The line still moves at the speed of the empty station.
Fat-soluble vitamins: context is delivery
Vitamin D3 is better at raising and holding serum 25-hydroxyvitamin D than D2. That one is established, replicated, and boring, which is the best kind of claim. We pair D3 with K2 because the two are halves of one system. D increases how much calcium you absorb. K2 activates osteocalcin and matrix Gla protein, the proteins that put that calcium into bone and keep it out of arterial walls. And here is the connection most formulators miss: D upregulates the production of those very proteins. Give D without K2 and you are printing more of the calcium-routing proteins while leaving them uncarboxylated, which is to say inactive. D writes the checks. K2 signs them. Dosing D alone at modern levels without its cofactor is a formulation error, and I treat it as one.
But the delivery detail matters as much as the form. D3, K2, and omega-3s absorb with dietary fat. A D3 capsule on an empty stomach at 6 a.m. is a worse supplement than the identical capsule with lunch. No formulation trick fixes an empty stomach.
This is also why the fat-solubles should ride together. D, K, E, and the omega-3s all board the same vehicle: they get emulsified by bile, packed into micelles, and shipped out of the enterocyte in chylomicrons. One meal with real fat in it triggers one bile release and builds one fleet of micelles, and every fat-soluble compound present at that moment gets a seat. Split them across the day and you are asking your gallbladder to run three deliveries where one would do, and the doses taken without fat mostly don't ship at all.
But shared transport is the shallow half of the story. The fat-solubles are wired together downstream of absorption, at the level of the receptors themselves. Vitamin D does not signal alone. Its receptor has to pair with the retinoid X receptor, whose ligand comes from vitamin A, before it can bind DNA and do anything. A and D are not neighbors. They are dance partners, and the dance requires both. The D-K2 relationship I described above is another instance of the same architecture: one vitamin induces the proteins, the other activates them. Vitamin E plays defense for the whole group. Omega-3s are long, polyunsaturated, and chemically eager to oxidize, in the softgel and in your cell membranes. E is the antioxidant that stands guard over those fatty acids, and higher omega-3 intake measurably raises the demand for it. And the omega-3s return the favor to everyone by being the fat: the delivery vehicle that carries D, K, and E across the intestinal wall is partly the omega-3 sitting in the same pouch. This is not a group of vitamins that happen to share a solubility. It is a metabolic committee, and a committee missing members makes worse decisions. Formulating them together is not convenience. It is how the system was built to receive them.
The counterargument, at full strength
A fair skeptic says: absorption differences mostly wash out at dose. Take enough magnesium oxide and you'll absorb enough magnesium. Cyanocobalamin has corrected B12 deficiency in millions of people. The premium-forms industry has an obvious incentive to inflate small kinetic differences into purchase decisions, and I run a company with that same incentive.
All true. Here is why the mechanism still holds anyway: dose escalation works on paper and fails in bowels and in behavior. The oxide dose that matches glycinate's absorbed magnesium is a dose many people cannot tolerate. And the conversion-step argument is not about averages. It is about the tail: the low-acid stomach, the slow enzyme, the person for whom the standard form quietly does nothing while their labs drift. A formulary is not built for the average patient. It is built so the tail patient isn't failed by default.
The last bioavailability variable is your pack architecture
Everything above is pharmacokinetics. If you are building packs on our formulary, it is also a set of decisions you are making for your customers, whether you make them deliberately or by default.
The ideal architecture is the one I would write as a clinician: fat-solubles anchored to the fattiest meal, methylated Bs in the morning where their energetic effect belongs, calcium and magnesium in the evening where glycine's calming lean is a feature, zinc separated from calcium because they compete for uptake. An AM/PM program buys you all of that.
I also know what a second pouch does to your unit economics, and I know many of you run single-pouch programs with magnesium sitting in a morning pack because that is what the margin allows. That is a legitimate trade, and here is the honest accounting of it. The form decisions hold at any time of day: glycinate in the morning is still absorbed like glycinate, and at these doses it will not sedate anyone. What you give up is the timing layer, the mineral separation and the meal anchoring, which is real but smaller than the form layer. Form is the floor of your product's quality. Timing is the ceiling. If economics force a choice, protect the floor.
A single pouch of well-chosen forms beats an AM/PM program built on oxides, and it isn't close.
Your customer cannot see any of this. They see your label next to a six dollar bottle on Amazon that uses the same nutrient names, and the difference lives entirely in words like glycinate and methylcobalamin that you will have to teach them to read. That is the work. The form determines what their gut can absorb. Your pack architecture determines what their gut ever sees.
The best-absorbed molecule in the world is the one your customer actually takes.
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.